Evidence map›Paper›PMID 32182734›Full record

ArticleInternational journal of molecular sciences2020

Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery.

Qi Shuai, Yue Cai, Guangkuo Zhao, Xuanrong Sun

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Development of Responsive Nanoparticles for Cancer Therapy.International journal of molecular sciences · 2023
    Article
  5. Article
  6. Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA.International journal of molecular sciences · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qi ShuaiCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310006, China.
Yue CaiCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310006, China.
Guangkuo ZhaoCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310006, China.
Xuanrong SunCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310006, China.ORCID 0000-0001-5414-9300

Funding

National Natural Science Foundation of China NO.21506192Natural Science Foundation of Zhejiang Province NO.LY16E030010
6 · The paper itself

Abstract

On account of their excellent capacity to significantly improve the bioavailability and solubility of chemotherapy drugs, amphiphilic block copolymer-based micelles have been widely utilized for chemotherapy drug delivery. In order to further improve the antitumor ability and to also reduce undesired side effects of drugs, cell-penetrating peptides have been used to functionalize the surface of polymer micelles endowed with the ability to target tumor tissues. Herein, we first synthesized functional polyethylene glycol-polylactic acid (PEG-PLA) tethered with maleimide at the PEG section of the block polymer, which was further conjugated with a specific peptide, the transactivating transcriptional activator (TAT), with an approved capacity of aiding translocation across the plasma membrane. Then, TAT-conjugated, paclitaxel-loaded nanoparticles were self-assembled into stable nanoparticles with a favorable size of 20 nm, and displayed a significantly increased cytotoxicity, due to their enhanced accumulation via peptide-mediated cellular association in human breast cancer cells (MCF-7)

Indexed as

AnimalsAntineoplastic Agents, PhytogenicCell Line, TumorCell MembraneCell-Penetrating PeptidesDrug CarriersEndoplasmic ReticulumFemaleGene Products, tatHumansMCF-7 CellsMiceMice, Inbred BALB CMice, Inbred ICRMicellesNanoparticlesAntineoplastic Agents, PhytogenicCell-Penetrating PeptidesDrug CarriersGene Products, tatMicellesPaclitaxelPolyestersPolyethylene Glycolspoly(lactide)Polymersactive tumor targetingcell-penetrating peptidenanoparticlesPEG-PLA

Identifiers

PMID32182734
PMCPMC7084196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.